ctrl K

AI Score

Unlock

BioMarin Pharmaceutical I... (BMRN)

AI Score

Unlock

67.93

-2.76 (-3.90%)

At close: Apr 01, 2025, 3:59 PM

67.20

-1.07%

After-hours: Apr 01, 2025, 07:06 PM EDT

BioMarin Pharmaceutical Income Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Revenue	2.85B	2.42B	2.1B	1.85B	1.86B
Cost of Revenue	580.24M	577.07M	483.67M	470.51M	524.27M
Gross Profit	2.27B	1.84B	1.61B	1.38B	1.34B
Operating Income	484.21M	194.44M	57.55M	-60.01M	-96.26M
Interest Income	74.88M	58.34M	18.03M	10.48M	16.61M
Pretax Income	541.76M	188.56M	149.58M	-75.35M	-42.32M
Net Income	426.86M	167.65M	141.56M	-64.08M	854.03M
Selling & General & Admin	1.01B	937.3M	854.01M	759.38M	737.67M
Research & Development	747.18M	746.77M	649.61M	628.79M	628.12M
Other Expenses	33.28M	n/a	67.19M	69.93M	66.66M
Operating Expenses	1.79B	1.75B	1.57B	1.46B	1.43B
Interest Expense	12.34M	17.34M	15.97M	15.34M	29.31M
Selling & Marketing Expenses	476.7M	488.4M	450.3M	405.1M	403.4M
Cost & Expenses	2.37B	2.27B	2.05B	1.93B	1.96B
Income Tax	114.9M	20.92M	8.02M	-11.27M	-901.42M
Shares Outstanding (Basic)	190.03M	187.83M	185.27M	182.85M	180.8M
Shares Outstanding (Diluted)	196.71M	191.59M	188.96M	182.85M	191.68M
EPS (Basic)	2.13	0.89	0.76	-0.35	4.75
EPS (Diluted)	n/a	n/a	n/a	n/a	n/a
EBITDA	650.53M	310.28M	267.51M	48.03M	-5.85M
Depreciation & Amortization	96.43M	104.39M	101.97M	108.04M	105.88M